Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Cellular and Molecular Biology

Comment on ‘Use the term “infiltrative” instead of “replacement” when defining histopathological growth pattern in patients with liver cancer’ by Kong B et al.

British Journal of Cancer volume 128, pages 705–706 (2023)Cite this article

Subjects

Dear Editor,

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Haematoxylin- and eosin-stained tissue section of a breast cancer liver metastasis with a replacement histopathological growth pattern (scale bar: 50 µm).

References

  1. Kong B, Zhang Q, Zhang G. Use the term “infiltrative” instead of “replacement” when defining histopathological growth pattern in patients with liver cancer. Br J Cancer. 2023 (this issue).

  2. Latacz E, Höppener D, Bohlok A, Leduc S, Tabariès S, Fernández Moro C, et al. Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights. Br J Cancer. 2022;127:988–1013.

    Article  PubMed  Google Scholar 

  3. Vermeulen PB, Colpaert C, Salgado R, Royers R, Hellemans H, Van Den Heuvel E, et al. Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia. J Pathol. 2001;195:336–42.

    Article  CAS  PubMed  Google Scholar 

  4. Bohlok A, Vermeulen P, Leduc S, Latacz E, Botzenhart L, Richard F, et al. Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients. npj Breast Cancer. 2020;6:64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Bridgeman VL, Vermeulen PB, Foo S, Bilecz A, Daley F, Kostaras E, et al. Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models. J Pathol. 2017;241:362–74.

    Article  CAS  PubMed  Google Scholar 

  6. Matsumoto K, Yoshitomi H, Rossant J, Zaret KS. Liver organogenesis promoted by endothelial cells prior to vascular function. Science. 2001;294:559–63.

    Article  CAS  PubMed  Google Scholar 

  7. Teuwen LA, De Rooij LPMH, Cuypers A, Rohlenova K, Dumas SJ, García-Caballero M, et al. Tumor vessel co-option probed by single-cell analysis. Cell Rep. 2021;35:109253.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

The research projects of PV and LD are funded by the Koning Boudewijnstichting (King Baudouin Foundation)—Fonds Oncologie Augustinus.

Author information

Authors and Affiliations

  1. Translational Cancer Research Unit, GZA Hospital Sint-Augustinus & University of Antwerp, Antwerp, Belgium

    Peter Vermeulen, Emily Latacz, Laura Hendrickx, Michelle Van den Hauwe & Luc Dirix

Authors
  1. Peter Vermeulen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emily Latacz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Laura Hendrickx
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michelle Van den Hauwe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Luc Dirix
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed equally to writing the manuscript.

Corresponding author

Correspondence to Peter Vermeulen.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

Not applicable.

Consent to publish

Not applicable.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Vermeulen, P., Latacz, E., Hendrickx, L. et al. Comment on ‘Use the term “infiltrative” instead of “replacement” when defining histopathological growth pattern in patients with liver cancer’ by Kong B et al.. Br J Cancer 128, 705–706 (2023). https://doi.org/10.1038/s41416-023-02173-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41416-023-02173-6

Search

Advanced search

Quick links